Disparities in Racial Representation in Cosmetic Dermatology Clinical Trials
Recommended Citation
Sullivan C, Ituarte B, Adebayo O, Reagen C, Wei E. Disparities in Racial Representation in Cosmetic Dermatology Clinical Trials. J Am Acad Dermatol 2026; 95(1):AB160.
Document Type
Conference Proceeding
Publication Date
7-1-2026
Publication Title
J Am Acad Dermatol
Keywords
Dermatology
Abstract
Despite growing interest in cosmetic procedures across all demographics in the United States, cosmetic dermatology research remains skewed toward White individuals. Patients with skin of color are consistently underrepresented in literature, textbook images, and research studies. Without diverse participation in clinical trials, disparities among non-White populations cannot be addressed. This study aims to characterize racial representation in US cosmetic dermatology clinical trials. ClinicalTrials.gov was queried for trials completed from 2000-2023 using search terms “hair removal,” “hyperhidrosis,” “rhytides,” “melasma,” “skin cosmetics,” “skin laxity,” and “solar lentigines.” Percentages of participation were recorded for American Indian and Alaska Native (AIAN), Asian, Native Hawaiian/Pacific Islander (NHPI), Black, White, multiple, and unknown race. ANOVA testing revealed significant differences in representation (p<0.001). Of 114 completed trials, 76 (66.7%) reported race. On average, participants were 76.04% White, 6.60% Black, 5.87% Asian, 0.97% multiracial, 0.39% AIAN, 0.16% NHPI, and 6.91% unknown. Non-White minorities were underrepresented compared to 2020 US census data, especially for Black (6.6% of trial participants vs 12.4% of US population) and multiracial (0.97% vs 10.2%). Thirty trials enrolled >90% White participants. Overall, cosmetic dermatology clinical trials demonstrate significant underrepresentation of non-White racial groups. Diverse participation in trials is essential to ensuring generalizability of results, safety of treatments, and equity among patients seeking cosmetic dermatology care. Future research should explore strategies for increased recruitment of underrepresented populations and further investigate racial disparities in specific areas of cosmetic dermatology.
Volume
95
Issue
1
First Page
AB160
